Florey Institute

New mRNA method targets Tau Protein in Alzheimer’s disease

Researchers at The Florey Institute have developed a novel method using mRNA technology to specifically target the harmful tau protein, which accumulates in the brains of dementia patients, including those with Alzheimer's disease. mRNA technology has primarily been used in vaccines, particularly those designed to combat COVID-19. However, The Florey's...